Decreased tumour necrosis factor-beta production in TNFB(*)2 homozygote: An important predisposing factor of lupus nephritis in Koreans

Lupus

Volumn 6, Issue 7, 1997, Pages 603-609

  Lee, Sang Heon ^a   Park, Sung Hwan ^a   Min, Jun Ki ^a   Kim, Sung Il ^a   Yoo, Wan Hee ^a   Hong, Yeon Sik ^a   Park, Jae Ho ^a   Cho, Chul Soo ^a   Kim, Tai Gyu ^b   Han, Hoon ^b   Kim, Ho Youn ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Lupus nephritis; SLE; TNF beta; TNFB gene

Indexed keywords

DNA MARKER; LYMPHOTOXIN; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOASSAY; BLOOD; CELL STRAIN L 929; CONTROLLED STUDY; DISEASE MARKER; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE CONTROL; HOMOZYGOTE; HUMAN; HUMAN CELL; KOREA; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SECRETORY CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

EID: 9844235342     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600708     Document Type: Article

References (32)

1. Howard PF et al. Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med 1986; 31: 187-193.
2. Froneck Z et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum 1990; 33: 1542-1553.
3. Arnett FC, Reveille JD. Genetics of systemic lupus erythematosus. Rheum Clin North Am 1992; 18: 865-892.
4. Hong KH et al. Association of complement C4 and HLA-DR alleles with systemic lupus erythematosus in Koreans. J Rheumatol 21: 442-447.
5. Carrol MC et al. Linkage mapping of the human major histocompatibility complex by pulsed field gel electrophoresis. Proc Natl Acad Sci USA 1987; 84: 8235-8239.
6. Dunham I et al. Molecular mapping of the human major histocompatibility complex by pulsed field gel eletrophoresis. Proc Natl Acad Sci USA 1987; 84: 7237-7241.
7. Webb GC, Chaplin DD. Genetic variability at the human tumor necrosis factor loci. J Immunol 1990; 145: 1278-1285.
8. Kim TG et al. Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population. Hum Immunol 1996; 46: 10-17.
9. Jacob CO. Tumor necrosis factor alpha in autoimmunity. Pretty girl or old witch. Immunol Today 1992; 13: 122-125.
10. Jacob CO, McDevitt HO. Tumor necrosis factor-α in murine autoimmune lupus nephritis. Nature 1988, 331: 356-358.
11. 1 mice. Clin Immunol Immunopathol 1989; 52: 421-434.
12. Messer G et al. Polymorphic structure of the rumor necrosis factor (TNF) locus. An NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 1991; 173: 209-215.
13. Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
14. Adelman DC, Wallace DJ, Klinenberg JR. Thirty-four-year delayed-onset lupus nephritis: a case report. Arthritis Rheum 1987; 30: 479-480.
15. Hogan MM, Vogel SN. Production of tumor necrosis factor by rIFN-γ-primed C3H/HeJ(Lpsd) macrophages requires the presence of lipid-A-associated peptides. J Immunol Methods 1988; 95: 99-105.
16. Mosmann T. Rapid colormetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
17. Messer G et al. Allelic variation in the TNF-β gene does not explain the low TNF-β responses in patients with primary biliary cirrhosis. Scand J Immunol 1991; 34: 735-740.
18. Ruddle NH. Tumor necrosis factor-beta/lymphotoxin-alpha. In: Thomson (ed). Cytokine Handbook, 2nd edn. Academic Press: New York, 1994, pp 311-313.
19. Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 1986; 320: 584-588.
20. Janssen O, Kabelitz D. Tumor necrosis factor selectively inhibits activation of human B cells by Epstein-Barr virus. J Immunol 1988; 140: 125-130.
21. Jacob CO et al. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor ct: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA, 1990; 87: 1233-1237.
22. Mitamura K et al. Impared tumor necrosis factor-α (TNF-α) production and abnormal B cell response to TNF-α in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1991; 85: 386-391.
23. Watanabe Y, Jacob CO. Regulation of MHC class II antigen expression: opposing effect of TNF-α on IFN-r induced HLA-DR and la expression depends on the maturation and differentiation stage of the cell. J Immunol 1991; 146: 899-905.
24. Leewenberg JFM et al. Effects of tumor necrosis factor on the interferon-γ-induced major histocompatibility complex II antigen expression by human endothelial cells Ear J Immunol 1988; 18: 1469-1475.
25. Greenwood BM, Herrick EM, Voller A. Suppression of autoimmune disease in NZB and (NZW × NZB)F1 hybrid mice by infection with malaria. Nature 1970; 226: 266-267.
26. Adebajo AO. Does tumor necrosis factor protect against lupus in west Africa? Arthritis Rheum 1982; 35: 839-840.
27. Hashimoto H, Tsuda H, Matsumoto T. HLA antigens association with systemic lupus erythematosus. J Rheumatol 1985; 12: 919-923.
28. Hawkins BR et al. Strong association between major histocompatibility complex and systemic lupus erythematosus. J Rheumatol 1987; 14: 1128-1131.
29. Bettinotti MP et al. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus. Immunogenetics 1993; 371 449-454.
30. Alfonso SD, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promotor region. Immunogenetics 1994; 39: 150-154.
31. Wilson AG et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994; 24: 191-195.
32. Pociot F et al. No independent association between a tumor necrosis factor-α promotor region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 3043-3049.